Quarterly report on the progress of segregation campus and medical treatment of sleeping sickness in Uganda ; For the quarter December 1st , 1907-February 29th, 1908 / by Captain A.C.H Gray, R.A.M.C.
- Gray, Arthur Claypon H.
- Date:
- 1908
Licence: In copyright
Credit: Quarterly report on the progress of segregation campus and medical treatment of sleeping sickness in Uganda ; For the quarter December 1st , 1907-February 29th, 1908 / by Captain A.C.H Gray, R.A.M.C. Source: Wellcome Collection.
Provider: This material has been provided by The Royal College of Surgeons of England. The original may be consulted at The Royal College of Surgeons of England.
29/38 page 27
![caused frequent salivation of a temporary character, not exceeding three to five days.” As can be seen from the tables (XXI-XXVI), Drs. Goodliffe and Bayon have so far been very successful with this treatment at Sesse. It must be remembered, however, that it is only two months since this treatment was started on Sesse. There is also another point about treatment on Sesse. As will be seen from the tables comparing the results of Atoxyl treatment alone at the various camps since December 1, 1907 (table iSTo. XX), the Sesse death- rate is very much lower than at other camps. Xow the methods of Atoxyl treatment since December 1, 1907, have practically been the same at all camps, therefore it looks very much as if there was a milder type of disease on Sesse than on the mainland. If this is true it would explain the great difference in the death-rate observed by us in our mainland camps and that already reported by the German Commission at their former camp on Sesse. Treatment with * Soamin (Sodium-amino-phenyl-arsinate ; B. W. & Co.). Treatment with Soamin has been carried out on a small scale on Kyagwe Camp by Dr. van Someren, who strongly urges its more general use as, in his opinion, his results with it are as good as his results with Atoxyl. Dr. van Someren also lays stress on the uniformity of the different samples of this preparation and points out that its cost is only one-third of that of Atoxyl. A large consignment of Kharsin f has now been ordered so that very shortly it will receive an extensive trial. Dr. van Someren’s report on “ Soamin ” is given in detail:— Sir, I have the honour in accordance with the Principal Medical Officer’s request to submit to you a report on the administration of “ Soamin ” (sodium-amino-phenyl-arsinate, Burroughs Wellcome and Co.) in the treatment of sleeping sickness. Mj fiist trial of this drug was in September, 1907, with some samples sen me by Messrs. Burroughs Wellcome and Co., and though the quantity supplied was too small for a complete trial, the results were sufficiently encouraging to enable me to recommend a further trial. 1 received further quantities from them in December, 1907, and .. , 7,trom Wu 011 January 23, 1908. It is to be regretted, I think, .Y3 suPP1y was not sufficient for treating, say, 50 or 100 patients, of persons ^°ln^ v*ew testing for its toxicity over a large number Sf“ples,were in $ tabloid form, fairly soluble in cold not kppn S°u1 ^ kufc the solution had a slight yellow colour and did not keep so weH as that of the powder form. the tab hi ir/ m!fht J°e (*uti to some decomposition having occurred in cnetebloid, they are therefore not to be recommended, samples and literature8dealTnYYi-m notc> P- D- Owing to some confusion between substance which was aflerw f I ^ ?/' va“Someren adopted the name Kharsin for the t It wITL ( , ?Var,is called b-v Mossrs- burroughs Wellcome & Co. Soamin. [Ed.] This substance, the met hVlTa'Ug l° tb° ul)ovc'lon,ioned error in nomenclature. b'Jcn abandoned. [Ed ] ' omolo8ue of Soamin, proved most unsatisfactory, and its use has [Ed[] probable, but not certain, that the tabloids consisted of Orsudan and not of Soamin.](https://iiif.wellcomecollection.org/image/b22470451_0031.jp2/full/800%2C/0/default.jpg)
